IMR Press / JIN / Volume 21 / Issue 4 / DOI: 10.31083/j.jin2104104
Open Access Editorial
Cerebrospinal Fluid Dynamics Following Ventriculoperitoneal Shunt in Hydrocephalus: Do Technological Advancements Avoid Complications?
Show Less
1 Neurosurgical Unit, Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), University of Palermo, 90100 Palermo, Italy
*Correspondence: giovanni.grasso@unipa.it (Giovanni Grasso)
Academic Editor: Rafael Franco
J. Integr. Neurosci. 2022, 21(4), 104; https://doi.org/10.31083/j.jin2104104
Submitted: 7 April 2022 | Revised: 28 April 2022 | Accepted: 28 April 2022 | Published: 1 June 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

Despite a relatively high risk of complication and failure, ventriculoperitoneal shunting (VPS) is the most common approach to surgically treat chronic hydrocephalus [1, 2]. Although hydrocephalic patient mortality has been significantly reduced by introducing ventricular shunt systems, a wide variety of mid and long-term complications principally related to valve-regulated shunts are encountered and these underscore the complex pathophysiology of this condition [3, 4].

Shunt malfunctions have been classified into three groups: (1) Mechanical failure related to improper functioning of the device, including obstructions, ruptures, migrations, and disconnection; (2) Infections related to colonization of implanted materials and development of clinical infection either of the CSF inside the shunt or the soft tissue around it; and (3) Functional issues related to the hydrodynamic properties of the shunt [5].

We have evaluated the long-term results of shunt therapy in patients with idiopathic normal pressure hydrocephalus (iNPH) with a follow-up period spanning ten years [1], this represents the most extended follow-up study conducted to date in the literature. We showed that VPS is a safe modality capable of improving symptoms in most patients, including long-term symptom management. Compared with other symptoms, gait disturbance showed sustained improvement following shunting, VPS displays a low complication rate, and this approach has met with long-term therapeutic success over for >70% of patients. In a ten-year follow-up study involving 14,455 patients who underwent VPS, the cumulative complication rate at five years was 32% and obstructive hydrocephalus was found to increase the risk of shunt complications [6]. Due to this high complication rate, other surgical approaches, based not on flow diversion, but tailored to re-establish physiologic CSF dynamics [7, 8, 9] have been proposed. For instance, in cases of hydrocephalus following aneurysmal subarachnoid hemorrhage, lamina terminalis fenestration (LTF) allows the removal of blood components from the subarachnoid space and reduces paravascular pressure, thus decreasing post-hemorrhagic obstruction and brain swelling [10, 11, 12]. However, the efficacy of LTF for decreasing shunt-dependency requires further investigation since fibrotic degeneration of arachnoid granulations is not prevented using this approach [13, 14].

Shunt overdrainage is a common complication following VPS. This was first reported by Dandy in 1932 where an account of sudden drainage of cerebrospinal fluid (CSF) after surgery lead to intracranial hypotension with ventricular collapse [15] was detailed. In 1982, Hyde-Rowan et al. [16] described this condition, termed slit ventricle syndrome, that is characterized by intermittent headache (from 10 to 90 min), small ventricles on imaging studies, and slow filling of the valve reservoir on palpation due to the postural changes of CSF drainage. To date, shunt overdrainage is associated with severe headaches that interfere with activities of daily living in patients with CSF diversion systems and those with smaller or normal cerebral ventricles [17].

Pathophysiology of shunt overdrainage and slit ventricle syndrome has not been completely established and several theories are actively under investigation including acquired craniocerebral disproportion [18], periventricular gliosis [19], capillary absorption laziness [20], and pulsatile vector theory [21]. Moreover, the siphon effect is primarily associated with CSF overdrainage. In the supine position, the intracranial pressure is equivalent to that of the subarachnoid spinal space, however in the standing position, intracranial pressure falls to 0 mm H2O (or to negative pressures) and increases up to 500 ± 50 mm H2O at the lumbar level. Assuming the cranial-abdominal distance as approximately 50 cm, when patients go from lying down to standing, a gravity gradient forms between the ventricles and peritoneal cavity that is equivalent to the weight of the column of CSF inside the system (i.e., hydrostatic pressure) that is dependent on the height or distance between both cavities [22]. Consequently, a hydrostatic suction force (of up to –500 mm H2O in this case) due to a siphon effect can easily exceed the valve’s opening pressure even when the ventricular pressure is zero or negative. This results in shunt overdrainage and consequential ventricular collapse. Therefore, this theory prompts treatment of overdrainage by mitigating the siphon effect using anti-siphon devices or other systems that increase the resistance to drainage across the valve [15, 23].

Panagopoulos D et al. [24] conducted a narrative literature review focused on an analysis of shunt overdrainage and slit ventricle syndrome. The authors also reported technological advancements aimed in counteracting these treatment side effects. Moreover, they described CSF hydrodynamics in patients who undergo CSF flow diversion and reported evidence supporting a role for internal jugular vein collapse as a result of a moderate decrease of intracranial pressure when patients adopt a vertical position. Further, this report described the most relevant clinical and radiological criteria associated with slit ventricle syndrome, specifically, the most accepted pattern of overdrainage stemming from negative pressure, an on-off symptom complex, recurring proximal ventricular dysfunction, chronic subdural collections due to shunt overdrainage, and headaches unrelated to shunt function.

Overall, this study sought to clarify a complex and poorly understood condition which often influences patient prognosis. The authors are to be commended for bringing these issues to light as additional tailored preclinical and clinical studies are necessary to provide a set of best management principles for hydrocephalus-affected patients.

Author Contributions

FT—Writing – original draft, Conceptualization. GG—Writing – original draft, Supervision.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Not applicable.

Funding

This research received no external funding.

Conflict of Interest

The authors declare no conflict of interest. GG is serving as one of the Editorial Board members of this journal. We declare that GG had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to RF.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References
[1]
Grasso G, Torregrossa F, Leone L, Frisella A, Landi A. Long-Term Efficacy of Shunt Therapy in Idiopathic Normal Pressure Hydrocephalus. World Neurosurgery. 2019; 129: e458–e463.
[2]
Grasso G. Letter: Cerebrospinal Fluid Shunting Improves Long-Term Quality of Life in Idiopathic Normal Pressure Hydrocephalus. Neurosurgery. 2020; 87: E432–E433.
[3]
Hanak BW, Bonow RH, Harris CA, Browd SR. Cerebrospinal Fluid Shunting Complications in Children. Pediatric Neurosurgery. 2017; 52: 381–400.
[4]
Torregrossa F, Grasso G. The Quest for Predictors of Shunt-Dependent Chronic Hydrocephalus after Aneurysmal Subarachnoid Hemorrhage: toward a Tailored Approach for Permanent Shunt-Dependency Following Aneurysmal Subarachnoid Hemorrhage. World Neurosurgery. 2022; 157: 96–98.
[5]
Jain H, Sgouros S, Walsh AR, Hockley AD. The treatment of infantile hydrocephalus: ”differential-pressure” or ”flow-control” valves. A pilot study. Child’s Nervous System. 2000; 16: 242–246.
[6]
Wu Y, Green NL, Wrensch MR, Zhao S, Gupta N. Ventriculoperitoneal shunt complications in California. Neurosurgery. 2007; 61: 557–563.
[7]
Tomasello F, d’Avella D, de Divitiis O. Does Lamina Terminalis Fenestration Reduce the Incidence of Chronic Hydrocephalus after Subarachnoid Hemorrhage? Neurosurgery. 1999; 45: 827–832.
[8]
Cherian I, Grasso G, Bernardo A, Munakomi S. Anatomy and physiology of cisternostomy. Chinese Journal of Traumatology. 2016; 19: 7–10.
[9]
Grasso G, Alafaci C, Passalacqua M, Morabito A, Buemi M, Salpietro FM, et al. Assessment of Human Brain Water Content by Cerebral Bioelectrical Impedance Analysis: a New Technique and its Application to Cerebral Pathological Conditions. Neurosurgery. 2002; 50: 1064–1074.
[10]
Cherian I, Beltran M, Landi A, Alafaci C, Torregrossa F, Grasso G. Introducing the concept of “CSF-shift edema” in traumatic brain injury. Journal of Neuroscience Research. 2018; 96: 744–752.
[11]
Cherian I, Bernardo A, Grasso G. Cisternostomy for Traumatic Brain Injury: Pathophysiologic Mechanisms and Surgical Technical Notes. World Neurosurgery. 2016; 89: 51–57.
[12]
Cherian I, Burhan H, Dashevskiy G, Motta SJH, Parthiban J, Wang Y, et al. Cisternostomy: a Timely Intervention in Moderate to Severe Traumatic Brain Injuries: Rationale, Indications, and Prospects. World Neurosurgery. 2019; 131: 385–390.
[13]
Chen S, Luo J, Reis C, Manaenko A, Zhang J. Hydrocephalus after Subarachnoid Hemorrhage: Pathophysiology, Diagnosis, and Treatment. BioMed Research International. 2017; 2017: 1–8.
[14]
Torregrossa F, Grasso G. Therapeutic Approaches for Cerebrovascular Dysfunction after Aneurysmal Subarachnoid Hemorrhage: an Update and Future Perspectives. World Neurosurgery. 2022; 159: 276–287.
[15]
Ros B, Iglesias S, Martín Á, Carrasco A, Ibáñez G, Arráez MA. Shunt overdrainage syndrome: review of the literature. Neurosurgical Review. 2018; 41: 969–981.
[16]
Hyde-Rowan MD, Rekate HL, Nulsen FE. Reexpansion of previously collapsed ventricles: the slit ventricle syndrome. Journal of Neurosurgery. 1982; 56: 536–539.
[17]
Rekate HL. Shunt-related headaches: the slit ventricle syndromes. Child’s Nervous System. 2008; 24: 423–430.
[18]
Albright AL, Tyler-Kabara E. Slit-ventricle Syndrome Secondary to Shunt-induced Suture Ossification. Neurosurgery. 2001; 48: 764–770.
[19]
Del Bigio MR. Neuropathological Findings in a Child with Slit Ventricle Syndrome. Pediatric Neurosurgery. 2002; 37: 148–151.
[20]
Jang M, Yoon SH. Hypothesis for intracranial hypertension in slit ventricle syndrome: New concept of capillary absorption laziness in the hydrocephalic patients with long-term shunts. Medical Hypotheses. 2013; 81: 199–201.
[21]
Preuss M, Hoffmann K-, Reiss-Zimmermann M, Hirsch W, Merkenschlager A, Meixensberger J, et al. Updated physiology and pathophysiology of CSF circulation—the pulsatile vector theory. Child’s Nervous System. 2013; 29: 1811–1825.
[22]
Kajimoto Y, Ohta T, Miyake H, Matsukawa M, Ogawa D, Nagao K, et al. Posture-related changes in the pressure environment of the ventriculoperitoneal shunt system. Journal of Neurosurgery. 2000; 93: 614–617.
[23]
Pinto FC, Pereira RM, Saad F, Teixeira MJ. Performance of fixed-pressure valve with antisiphon device SPHERA(®) in hydrocephalus treatment and overdrainage prevention. Arquivos de Neuro-Psiquiatria. 2012; 70: 704–709.
[24]
Panagopoulos D, Stranjalis G, Gavra M, Boviatsis E, Korfias S. Shunt Over-drainage, Slit Ventricle Syndrome, Programmable Valves and Anti-Siphon Devices. A Narrative Review of a Multifactorial and Intractable Problem. Journal of Integrative Neuroscience. 2022; 21: 084.
Share
Back to top